Rob  Sage CEO
There Is Value To Being At The Center Of The JPM Universe
Rob Wright provides a bit of his perspective on the 37th Annual J.P. Morgan Healthcare Conference.  Continue Reading..
From Radboud UMC To Pivot Park — Day 2 Of The Netherlands' Biopharma Press Tour
Rob Wright shares experiences from day two of recent press tour of the Netherlands’ biopharmaceutical industry.  Continue Reading..
CNS Summit 2018 Does Not Meet Expectations — It Exceeded Them
CNS Summit 2018 Does Not Meet Expectations — It Exceeded Them
Rob Wright shares what makes the CNS Summit the best conference he has ever attended.  Continue Reading..
Netherlands IMG_7911
The Netherlands — More Than Just The New Home Of The EMA
What sets the Netherlands biopharma sector apart from the rest of the world? That’s what Chief Editor Rob Wright hoped to find out as he began his press tour of the country’s biopharma industry.  Continue Reading..
Can China Be Trusted?
Can China Be Trusted?
Rob Wright discusses China’s history of intellectual property (IP) theft, and wonders if the government-sponsored 10-year initiative, Made in China 2025 (MIC 2025), could exacerbate the problem.  Continue Reading..
The Future Of Biopharma — Netherlands Style
Rob Wright shares what he looks forward to learning about during an upcoming press tour of the Netherlands, beyond the fact that the European Medicines Agency (EMA) will be relocating there in 2019.  Continue Reading..
What Mylan Could Learn About Accountability
Mylan’s inability to adequately supply its EpiPen during the 2018 back-to-school time is the latest example of corporate leadership lacking accountability.  Continue Reading..
GMO Tomato Injection
Are Genetically Modified Organisms (GMO) A Blessing Or A Curse?
A question about GMOs submitted to our editorial board leads us to look more closely into this issue and how it affects the pharma industry.  Continue Reading..
Amir Katali
Why A Biopharma Executive Founded A Game-Changing Conference
Amir Kalali, M.D., former global head of Quintiles (now IQVIA) neuroscience center of excellence, provides insight on why he decided to found an educational conference, The CNS Summit, while still working as a biopharmaceutical industry executive.  Continue Reading..
person on top of mountain
Is It Possible For A Biopharmaceutical Executive To Transcend Their Industry?
What current biopharma leaders have the potential to “transcend” beyond this industry? Chief Editor Rob Wright gives his top three choices.  Continue Reading..
Rob Wright author page

Rob Wright

Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL